Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 92.26M CAD in the quarter ending September 30, 2024, with 13.21% growth. This brings the company's revenue in the last twelve months to 348.64M, up 3.87% year-over-year. In the year 2023, Knight Therapeutics had annual revenue of 328.20M with 11.80% growth.

• Revenue (ttm): 348.64M
• Revenue Growth: +3.87%
• P/S Ratio: 1.64
• Revenue / Employee: 480.88K
• Employees: 725
• Market Cap: 563.65M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	328.20M	34.64M	11.80%
Dec 31, 2022	293.56M	50.09M	20.57%
Dec 31, 2021	243.48M	43.96M	22.03%
Dec 31, 2020	199.52M	152.06M	320.39%
Dec 31, 2019	47.46M	34.96M	279.69%